Bioray Pharmaceutical Co., Ltd.

This early-stage study tests a new drug called BR115 in 120 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety and find the right dose. Participants receive the drug weekly after an initial two doses in the…

This study compares a new drug, HS627, against an existing one, pertuzumab, when both are given with trastuzumab and chemotherapy before surgery for early or locally advanced HER2-positive breast cancer. The main goal is to see if HS627 can eliminate all signs of cancer in breast…

This study tests a new drug, zuberitamab, in 135 adults with primary membranous nephropathy, a kidney disease that causes protein leakage. The goal is to see if zuberitamab reduces protein in urine better than the standard drug cyclosporine. Participants receive either zuberitama…